subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: type 2 diabetes mellitus

tested_intervention: yes


subject: CHEBI:232617

object_name: plasma cell myeloma

tested_intervention: unsure


subject: UMLS:C2830136


subject: UNII:03J11K103C

subject_name: ALGELDRATE

object_name: dyspepsia


subject: UNII:03J11K103C

object_name: Dyspepsia, CTCAE


subject: UNII:03J11K103C

object_name: digestive system disorder


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:7915

subject_name: Pantoprazole


subject: CHEBI:7915


subject: CHEBI:7915


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:6904

subject_name: Metoprolol

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:6904

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:6904

object_name: morbid obesity


subject: CHEBI:6129

subject_name: Ketorolac

object_name: interstitial cystitis


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Acute HIV infection


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:161680

subject_name: Aztreonam


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:31781

subject_name: Lopinavir


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Subfertility


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Exsanguination


subject: CHEBI:3757

subject_name: Clonidine

object_name: neonatal abstinence syndrome


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: lichen planus


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:71219

object_name: Stage III Differentiated Thyroid Gland Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7


subject: CHEBI:71219

object_name: Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7


subject: CHEBI:71219

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:231005

object_name: breast carcinoma


subject: CHEBI:231005

object_name: breast cancer


subject: CHEBI:231005

object_name: breast neoplasm


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Malignant pleural effusion


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: chronic rhinosinusitis with nasal polyps


subject: MESH:C000708971

subject_name: genexol-PM

object_name: female reproductive organ cancer


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Depressed mood


subject: CHEBI:76016

object_name: Cancer patients and suicide and depression


subject: CHEBI:76016

object_name: Depressed - symptom


subject: CHEBI:76016

object_name: Depression, CTCAE


subject: CHEBI:145994

subject_name: Remdesivir


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate

object_name: fallopian tube carcinoma


subject: CHEBI:31587

object_name: fallopian tube cancer


subject: CHEBI:31587

object_name: ovarian cancer


subject: CHEBI:31587

object_name: ovarian neoplasm


subject: CHEBI:31587

object_name: ovarian carcinoma


subject: CHEBI:31587

object_name: peritoneum cancer


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: CHEBI:31596

subject_name: Febuxostat

object_name: contrast-induced nephropathy


subject: CHEBI:3175

subject_name: Brimonidine

object_name: ocular hypertension


subject: CHEBI:3175

object_name: Ocular hypertension


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:12990

object_name: breast carcinoma


subject: GTOPDB:12990

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: type 2 diabetes mellitus


subject: CHEBI:34574


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: CHEBI:5959

subject_name: Irbesartan

object_name: essential hypertension


subject: UMLS:C0591040

subject_name: Adenocor

object_name: Ischaemia coronary artery origin


subject: CHEBI:16335

subject_name: Adenosine


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide


subject: UMLS:C0590709

subject_name: Nitronal


subject: CHEBI:234112

subject_name: Cenobamate

object_name: idiopathic generalized epilepsy


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:25805

object_name: COPD, severe early onset


subject: CHEBI:25805

object_name: chronic obstructive pulmonary disease


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: PUBCHEM.COMPOUND:139596280

subject_name: Pegvaliase

object_name: phenylketonuria


subject: CHEBI:8382

subject_name: Prednisone

object_name: chronic graft versus host disease


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib


subject: UMLS:C5565994


subject: CHEBI:5062

subject_name: Finasteride

object_name: Muscle Atrophy


subject: CHEBI:5062

object_name: benign prostatic hyperplasia


subject: CHEBI:5062

object_name: hypogonadism, male


subject: CHEBI:5062

object_name: sarcopenia


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:135515

subject_name: Bendamustine

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:135515

object_name: lymphoid leukemia


subject: CHEBI:135515

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib


subject: PUBCHEM.COMPOUND:135565596


subject: PUBCHEM.COMPOUND:135565596


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEMBL.COMPOUND:CHEMBL3545231

object_name: Alzheimer disease


subject: GTOPDB:9340

subject_name: ontamalimab

object_name: ulcerative colitis


subject: GTOPDB:9340

object_name: inflammatory bowel disease 1


subject: UNII:6LGI7RV4PB


subject: UNII:6LGI7RV4PB


subject: UMLS:C5139910


subject: UMLS:C5139910


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: HMG COA reductase inhibitor adverse reaction


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:16112

subject_name: Chlorogenate

object_name: Advanced cancer


subject: CHEBI:68551

subject_name: Linaclotide

object_name: Chronic idiopathic constipation


subject: CHEBI:9112

subject_name: sennoside A


subject: DRUGBANK:DB15889

subject_name: Senna leaf


subject: CHEMBL.COMPOUND:CHEMBL2108558

subject_name: SENNA


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: UNII:T60AV22R32

subject_name: Chlorazine

object_name: glioblastoma


subject: UNII:T60AV22R32

object_name: Brain Stem Glioblastoma


subject: UNII:T60AV22R32

object_name: glioma susceptibility 1


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:3647


subject: CHEBI:3647


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:8382

subject_name: Prednisone

object_name: Becker muscular dystrophy


subject: CHEBI:8382

object_name: limb-girdle muscular dystrophy


subject: CHEBI:31355

subject_name: Carboplatin

object_name: lung cancer


subject: CHEBI:31355

object_name: lung neoplasm


subject: CHEBI:31355

object_name: lung carcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:6801

subject_name: Metformin

object_name: type 2 diabetes mellitus


subject: CHEBI:8228

subject_name: Pioglitazone


subject: PUBCHEM.COMPOUND:77528802

subject_name: Gepotidacin

object_name: gonorrhea


subject: UMLS:C5557572

subject_name: Pam3Cys-GDPKHPKSF XS15

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:233593

subject_name: Flumatinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:167309

subject_name: Methadone

object_name: sickle cell disease


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C3657751

object_name: Tay-Sachs disease


subject: UMLS:C3657751

object_name: GM2 gangliosidosis


subject: UMLS:C3657751

object_name: Sandhoff disease


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Central nervous system depression (disorder)


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:6801

object_name: gestational diabetes


subject: CHEBI:87681

subject_name: Ranolazine

object_name: myocardial ischemia


subject: CHEBI:87681

object_name: coronary atherosclerosis


subject: CHEBI:87681

object_name: Angina pectoris


subject: CHEBI:87681

object_name: coronary artery disorder


subject: CHEBI:87681

object_name: arteriosclerosis disorder


subject: CHEBI:50861

subject_name: Treprostinil

object_name: systemic sclerosis


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Neck Carcinoma


subject: UNII:PQX0D8J21J

object_name: head and neck neoplasm


subject: UNII:PQX0D8J21J

object_name: head and neck cancer


subject: UNII:PQX0D8J21J

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: UNII:PQX0D8J21J

object_name: Disseminated Malignant Neoplasm


subject: UNII:PQX0D8J21J

object_name: Embolism, Tumor


subject: UNII:PQX0D8J21J

object_name: Neoplasm Metastasis


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: fragile X syndrome


subject: UMLS:C2830156

object_name: generalized anxiety disorder


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: disseminated candidiasis


subject: PUBCHEM.COMPOUND:122173807

object_name: candidiasis, invasive


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: UMLS:C0812735


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:10023

subject_name: Voriconazole


subject: CHEBI:10023


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: bipolar depression


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: CHEBI:91541


subject: CHEBI:229236

subject_name: Fezolinetant

object_name: Hot Flashes, CTCAE


subject: CHEBI:229236

object_name: Hot flashes


subject: UMLS:C5139955

object_name: asthma


subject: UMLS:C4726648

subject_name: Quilizumab


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: nonpapillary renal cell carcinoma


subject: UNII:7K28NB895L

object_name: clear cell renal carcinoma


subject: UNII:7K28NB895L

object_name: renal cell adenocarcinoma


subject: UNII:7K28NB895L

object_name: renal cell carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C4520835

subject_name: Factor viii (antihemophilic factor, human) per i.u.

object_name: severe hemophilia A


subject: UMLS:C0700346

subject_name: Koate-DVI


subject: UMLS:C2726511

subject_name: Wilate


subject: UMLS:C4718976

subject_name: Beroctocog alfa


subject: UMLS:C0015506

subject_name: factor VIII


subject: UMLS:C4727060

subject_name: CXCR2 Antagonist QBM076

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C4727060

object_name: COPD, severe early onset


subject: UMLS:C4727060

object_name: chronic obstructive pulmonary disease


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: breast neoplasm


subject: UMLS:C4058551

subject_name: Paliperidone ER

object_name: schizophrenia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: ovarian cancer


subject: CHEBI:4026

object_name: ovarian neoplasm


subject: CHEBI:4026

object_name: ovarian carcinoma


subject: CHEBI:4026

object_name: primary peritoneal carcinoma


subject: CHEBI:4026

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:4026

object_name: peritoneal carcinoma


subject: CHEBI:4026

object_name: fallopian tube carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: UMLS:C2985191


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Androgen excess


subject: CHEBI:30314

object_name: female infertility


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: Fibrosis of endometrium


subject: PUBCHEM.COMPOUND:133604

object_name: female infertility of uterine origin


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN


subject: PUBCHEM.COMPOUND:21628493


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: adult germ cell tumor


subject: CHEBI:41879

object_name: germ cell tumor


subject: CHEBI:41879

object_name: childhood germ cell tumor


subject: CHEBI:41879

object_name: Germ Cell Cancer


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: PUBCHEM.COMPOUND:44215723

subject_name: Rolapitant


subject: PUBCHEM.COMPOUND:44215723


subject: PUBCHEM.COMPOUND:44215723


subject: PUBCHEM.COMPOUND:44215723


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Small cell lung cancer extensive stage


subject: PUBCHEM.COMPOUND:131769963

object_name: Small cell lung cancer recurrent


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: lymphatic malformation


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: CHEBI:3757

subject_name: Clonidine

object_name: septic shock


subject: UMLS:C4745006

object_name: glioblastoma


subject: UMLS:C4745006

object_name: Childhood Glioblastoma


subject: UMLS:C4745006

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:129264140

subject_name: Brigimadlin


subject: PUBCHEM.COMPOUND:129264140


subject: PUBCHEM.COMPOUND:129264140


subject: UNII:9A934ZAN94

subject_name: BRIGIMADLIN


subject: UNII:9A934ZAN94


subject: UNII:9A934ZAN94


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Metastatic Breast Carcinoma


subject: GTOPDB:11376

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: GTOPDB:11376

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: GTOPDB:11376

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:11376

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: CHEMBL.COMPOUND:CHEMBL4298056

subject_name: IMMUNOCYTOKINE NHS-IL12


subject: CHEMBL.COMPOUND:CHEMBL4298056


subject: CHEMBL.COMPOUND:CHEMBL4298056


subject: CHEMBL.COMPOUND:CHEMBL4298056


subject: CHEMBL.COMPOUND:CHEMBL4298056


subject: UMLS:C3273725


subject: UMLS:C3273725


subject: UMLS:C3273725


subject: UMLS:C3273725


subject: UMLS:C3273725


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Premature Labor


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEMBL.COMPOUND:CHEMBL4650525

object_name: HIV infection


subject: CHEBI:68590

subject_name: fidaxomicin

object_name: diarrhea


subject: CHEBI:68590

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:68590

object_name: Diarrhea, CTCAE


subject: CHEBI:68590

object_name: enterocolitis


subject: CHEBI:68590

object_name: Enterocolitis, CTCAE


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: colorectal neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Plasma cell myeloma recurrent


subject: CHEBI:90227

object_name: Plasma cell myeloma refractory


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: graft versus host disease


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:55379

subject_name: camphorsulfonic acid


subject: PR:000007170

subject_name: DNA excision repair protein ERCC-8


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: Cirrhosis


subject: UNII:21K6M2I7AG

object_name: liver cirrhosis


subject: UNII:21K6M2I7AG

object_name: Liver Fibrosis


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: UMLS:C0021741


subject: CHEBI:2668

subject_name: Amlodipine

object_name: hypertension


subject: CHEBI:2668

object_name: Hypertension, CTCAE


subject: UMLS:C0593466

subject_name: Potassium phosphate injection

object_name: nodular regenerative hyperplasia of the liver


subject: UMLS:C0593466

object_name: Postoperative Complications


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: head and neck cancer


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Light chain (AL) amyloidosis


subject: CHEBI:41879

object_name: CCND1 Gene Translocation


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: Chronic small plaque psoriasis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: liver carcinoma


subject: UMLS:C3641122


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Hermansky-Pudlak syndrome


subject: CHEBI:7986

object_name: hepatopulmonary syndrome


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: psoriasis


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Drug Interactions


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: EXCESS LMW-DNA


subject: CHEBI:39112

subject_name: Bosutinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0718234

subject_name: Acthar

object_name: optic neuritis


subject: CHEBI:33569

subject_name: noradrenaline

object_name: alopecia


subject: CHEBI:33569

object_name: Alopecia, CTCAE


subject: CHEBI:33569

object_name: radiodermatitis


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: schizophrenia


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Childhood Breast Carcinoma


subject: CHEBI:71954

object_name: breast carcinoma


subject: CHEBI:71954

object_name: breast cancer


subject: CHEBI:71954

object_name: ovarian cancer


subject: CHEBI:71954

object_name: ovarian neoplasm


subject: CHEBI:71954

object_name: ovarian carcinoma


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:231324

subject_name: alpelisib


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: CHEBI:49668

subject_name: Gefitinib

object_name: colorectal cancer


subject: CHEBI:49668

object_name: colorectal carcinoma


subject: CHEBI:49668

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: heart disorder


subject: CHEBI:28939

object_name: acute kidney failure


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: type 1 diabetes mellitus 1


subject: CHEBI:168396

object_name: type 1 diabetes mellitus


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UMLS:C0054946

subject_name: CD20 Antigens

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C0054946

object_name: B-cell neoplasm


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1


subject: PR:000001289


subject: CHEBI:6801

subject_name: Metformin

object_name: coronary artery disorder


subject: CHEBI:6801

object_name: coronary atherosclerosis


subject: CHEBI:135285

subject_name: Vildagliptin


subject: CHEBI:135285


subject: CHEBI:135285

object_name: type 2 diabetes mellitus


subject: CHEBI:75283

subject_name: Miltefosine

object_name: cutaneous leishmaniasis


subject: CHEBI:135905

subject_name: Terlipressin

object_name: septic shock


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Myelodysplasia


subject: CHEBI:49900

object_name: adult lymphoma


subject: CHEBI:49900

object_name: lymphoma


subject: CHEBI:49900

object_name: pediatric lymphoma


subject: CHEBI:49900

object_name: leukemia


subject: CHEBI:49900

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: renal cell carcinoma


subject: CHEBI:38940

subject_name: Sunitinib


subject: UMLS:C0939844

subject_name: red clover preparation

object_name: Oestrogen deficiency


subject: UMLS:C4520706

subject_name: Trifolium pratense whole extract


subject: UMLS:C1256207

subject_name: Trifolium pratense, flower essence


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:5778

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:5778

object_name: morbid obesity


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: diabetic retinopathy


subject: UNII:1P05PW62F3

object_name: severe nonproliferative diabetic retinopathy


subject: UNII:1P05PW62F3

object_name: diabetes mellitus


subject: UMLS:C2352201

subject_name: Conbercept


subject: UMLS:C2352201


subject: UMLS:C2352201


subject: CHEBI:188986

subject_name: idose

object_name: ocular hypertension


subject: CHEBI:188986

object_name: Ocular hypertension


subject: CHEBI:188986

object_name: open-angle glaucoma


subject: UNII:M75LUQ6DAW

object_name: Cough


subject: UNII:M75LUQ6DAW

object_name: Cough, CTCAE


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: ankylosing spondylitis


subject: CHEBI:3176

subject_name: Brinzolamide

object_name: OPTN-related open angle glaucoma


subject: CHEBI:3176


subject: CHEBI:3176


subject: CHEBI:3176


subject: CHEBI:36791

subject_name: Escitalopram

object_name: schizophrenia


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:16296

subject_name: D-Tryptophan

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16296

object_name: obesity


subject: CHEBI:16296

object_name: Obesity, CTCAE


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Thoracic Injury


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:3485

subject_name: Cefdinir

object_name: Acute bacterial sinusitis


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:487869

subject_name: clavulanate


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: psoriasis 14, pustular


subject: UNII:09495UIM6V

object_name: pustulosis palmaris et plantaris


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: HIV infection


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:601027

subject_name: Aliskiren

object_name: hypertension


subject: CHEBI:601027

object_name: Hypertension, CTCAE


subject: CHEBI:93775

subject_name: Amethopterin

object_name: neoplastic meningitis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C4745006

object_name: Solid Neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: liver carcinoma


subject: UNII:DPT0O3T46P

object_name: Tumour thrombosis


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: ovarian cancer


subject: UNII:D99YVK4L0X

object_name: ovarian neoplasm


subject: UNII:D99YVK4L0X

object_name: ovarian carcinoma


subject: UNII:D99YVK4L0X

object_name: primary peritoneal carcinoma


subject: UNII:D99YVK4L0X

object_name: papillary serous cystadenocarcinoma


subject: UNII:D99YVK4L0X

object_name: peritoneal carcinoma


subject: UNII:D99YVK4L0X

object_name: fallopian tube carcinoma


subject: UNII:D99YVK4L0X

object_name: fallopian tube cancer


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:4672

subject_name: Docetaxel

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:10838895

subject_name: Epothilone


subject: CHEBI:60831

subject_name: epothilone


subject: CHEBI:63605

subject_name: Ixabepilone


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: psoriasis-related juvenile idiopathic arthritis


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab


subject: UMLS:C4078397


subject: UMLS:C4085979

object_name: esophageal squamous cell carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Lung squamous cell carcinoma recurrent


subject: UNII:28X28X9OKV

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:31859

subject_name: Modafinil

object_name: alcohol abuse


subject: CHEBI:31859

object_name: alcohol dependence


subject: CHEBI:31859

object_name: cocaine abuse


subject: CHEBI:31859

object_name: alcohol-related disorders


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:7465


subject: CHEBI:7465


subject: CHEBI:7465


subject: UNII:W6I5QDT7QI

subject_name: Netarsudil

object_name: ocular hypertension


subject: UNII:W6I5QDT7QI

object_name: Ocular hypertension


subject: UNII:W6I5QDT7QI

object_name: OPTN-related open angle glaucoma


subject: UNII:W6I5QDT7QI

object_name: open-angle glaucoma


subject: CHEBI:177531

subject_name: Liafensine

object_name: Depressed mood


subject: CHEBI:177531

object_name: Cancer patients and suicide and depression


subject: CHEBI:177531

object_name: Depressed - symptom


subject: CHEBI:177531

object_name: Depression, CTCAE


subject: UMLS:C3886719


subject: UMLS:C3886719


subject: UMLS:C3886719


subject: UMLS:C3886719


subject: UMLS:C5417960

subject_name: Ficerafusp Alfa

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417960

object_name: squamous cell lung carcinoma


subject: UMLS:C5417960

object_name: anal canal squamous cell carcinoma


subject: UMLS:C5417960

object_name: skin squamous cell carcinoma


subject: UMLS:C5417960

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C5417960

object_name: head and neck neoplasm


subject: UMLS:C5417960

object_name: ovarian carcinoma


subject: UMLS:C5417960

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5417960

object_name: squamous cell carcinoma


subject: UMLS:C5417960

object_name: colorectal cancer


subject: UMLS:C5417960

object_name: colorectal carcinoma


subject: UMLS:C5417960

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5417960

object_name: pancreatic neoplasm


subject: UMLS:C5417960

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5417960

object_name: malignant pancreatic neoplasm


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:17061

object_name: malnutrition


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:64312

subject_name: Memantine

object_name: autism spectrum disorder


subject: UMLS:C2986393

object_name: melanoma


subject: CHEBI:71940

subject_name: Tadalafil

object_name: hypertension


subject: CHEBI:71940

object_name: Hypertension, CTCAE


subject: UniProtKB:P09290

subject_name: UL20_VZVD Protein UL20 homolog (sprot)

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UniProtKB:P09290

object_name: obesity


subject: UniProtKB:P09290

object_name: Obesity, CTCAE


subject: UMLS:C0169964

subject_name: somatropin

object_name: Prader-Willi syndrome


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Recurrent ovarian cancer


subject: CHEBI:36791

subject_name: Escitalopram

object_name: major depressive disorder


subject: CHEBI:36791

object_name: Abdominal pain


subject: CHEBI:36791

object_name: Abdominal Pain, CTCAE


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: UNII:TCN4MG2VXS

subject_name: Dapivirine

object_name: HIV infection


subject: CHEBI:190692

subject_name: substance P(3+)

object_name: type 1 diabetes mellitus 1


subject: CHEBI:190692

object_name: type 1 diabetes mellitus


subject: CHEBI:80308

subject_name: substance P


subject: CHEBI:80308


subject: UNII:675VGV5J1D

subject_name: SUBSTANCE P


subject: UNII:675VGV5J1D


subject: UMLS:C0038585

subject_name: Substance P


subject: UMLS:C0038585


subject: UMLS:C5564856

subject_name: SCTV01C vaccine


subject: UMLS:C5691129


subject: CHEBI:132082

subject_name: Entinostat

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:132082

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:132082

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:132082

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:132082

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:132082

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:132082

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: CHEBI:132082

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:132082

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:132082

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:132082

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:132082

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:132082

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:132082

object_name: adult acute monocytic leukemia


subject: CHEBI:132082

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:132082

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:132082

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:132082

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:132082

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:132082

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:132082

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:132082

object_name: chronic myelomonocytic leukemia


subject: CHEBI:132082

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:132082

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:132082

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:132082

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:132082

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:132082

object_name: Adult Erythroleukemia


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:132082

object_name: myelodysplastic syndrome with multilineage dysplasia


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:5TAA004E22

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:5TAA004E22

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:5TAA004E22

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:5TAA004E22

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:5TAA004E22

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: UNII:5TAA004E22

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: UNII:5TAA004E22

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:5TAA004E22

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:5TAA004E22

object_name: recurrent adult acute myeloid leukemia


subject: UNII:5TAA004E22

object_name: Adult Acute Myelomonocytic Leukemia


subject: UNII:5TAA004E22

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:5TAA004E22

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UNII:5TAA004E22

object_name: adult acute monocytic leukemia


subject: UNII:5TAA004E22

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: UNII:5TAA004E22

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UNII:5TAA004E22

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:5TAA004E22

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UNII:5TAA004E22

object_name: Adult Acute Monoblastic Leukemia


subject: UNII:5TAA004E22

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UNII:5TAA004E22

object_name: juvenile myelomonocytic leukemia


subject: UNII:5TAA004E22

object_name: chronic myelomonocytic leukemia


subject: UNII:5TAA004E22

object_name: acute megakaryoblastic leukemia in adult


subject: UNII:5TAA004E22

object_name: myelodysplastic syndrome with excess blasts


subject: UNII:5TAA004E22

object_name: Adult Pure Erythroid Leukemia


subject: UNII:5TAA004E22

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: UNII:5TAA004E22

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:5TAA004E22

object_name: Adult Erythroleukemia


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:5TAA004E22

object_name: myelodysplastic syndrome with multilineage dysplasia


subject: PR:000005931

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PR:000005931

object_name: Secondary Myelodysplastic Syndrome


subject: PR:000005931

object_name: De Novo Myelodysplastic Syndrome


subject: PR:000005931

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PR:000005931

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PR:000005931

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: PR:000005931

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: PR:000005931

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PR:000005931

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PR:000005931

object_name: recurrent adult acute myeloid leukemia


subject: PR:000005931

object_name: Adult Acute Myelomonocytic Leukemia


subject: PR:000005931

object_name: Previously Treated Myelodysplastic Syndrome


subject: PR:000005931

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PR:000005931

object_name: adult acute monocytic leukemia


subject: PR:000005931

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: PR:000005931

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: PR:000005931

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PR:000005931

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PR:000005931

object_name: Adult Acute Monoblastic Leukemia


subject: PR:000005931

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PR:000005931

object_name: juvenile myelomonocytic leukemia


subject: PR:000005931

object_name: chronic myelomonocytic leukemia


subject: PR:000005931

object_name: acute megakaryoblastic leukemia in adult


subject: PR:000005931

object_name: myelodysplastic syndrome with excess blasts


subject: PR:000005931

object_name: Adult Pure Erythroid Leukemia


subject: PR:000005931

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PR:000005931

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PR:000005931

object_name: Adult Erythroleukemia


subject: PR:000005931


subject: PR:000005931

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PR:000005931

object_name: myelodysplastic syndrome with multilineage dysplasia


subject: CHEBI:47657

subject_name: Roflumilast

object_name: chronic obstructive pulmonary disease


subject: CHEBI:47657

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:47657

object_name: metabolic syndrome X


subject: CHEBI:22586

subject_name: antioxidant

object_name: macular degeneration


subject: CHEBI:22586

object_name: age-related macular degeneration


subject: CHEBI:22586

object_name: retinitis pigmentosa 30


subject: CHEBI:22586

object_name: cataract


subject: CHEBI:22586

object_name: Cataract, CTCAE 3.0


subject: CHEBI:22586

object_name: Cataract, CTCAE 5.0


subject: CHEBI:22586

object_name: cataract on exam (physical finding)


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: CHEBI:66910

subject_name: Axitinib

object_name: renal carcinoma


subject: CHEBI:66910

object_name: kidney neoplasm


subject: CHEBI:66910

object_name: kidney cancer


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: childhood onset asthma


subject: CHEBI:84115

subject_name: Antazoline

object_name: paroxysmal atrial fibrillation


subject: CHEBI:84115

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: CHEBI:17754

subject_name: Glycerin

object_name: Encopresis


subject: CHEBI:17754

object_name: pervasive developmental disorder


subject: CHEBI:17754

object_name: autism


subject: CHEBI:17754

object_name: autism spectrum disorder


subject: UMLS:C5417819

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C0021741

subject_name: Actimmune

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: atopic conjunctivitis


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:71204

subject_name: bepotastine


subject: PUBCHEM.COMPOUND:46874763

object_name: pneumonia


subject: PUBCHEM.COMPOUND:46874763

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:46874763


subject: PUBCHEM.COMPOUND:46874763

object_name: Coronavinae infectious disease


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: epilepsy


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: acute coronary syndrome


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Heartburn


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: cancer


subject: CHEBI:6887

object_name: neoplasm


subject: CHEBI:231614

subject_name: Nivolumab

object_name: squamous cell carcinoma


subject: UMLS:C2346820


subject: UNII:WP6PY72ZH3

subject_name: Motolimod


subject: CHEBI:521033

subject_name: Dutasteride

object_name: prostate carcinoma


subject: CHEBI:521033

object_name: prostate cancer


subject: UMLS:C4044528


subject: UMLS:C4044528


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:6129

subject_name: Ketorolac

object_name: epicondylitis


subject: CHEBI:6129

object_name: Acquired trigger finger


subject: CHEBI:6129

object_name: trigger thumb


subject: CHEBI:6129

object_name: tenosynovitis


subject: CHEBI:6129

object_name: inflammatory disease


subject: CHEBI:6129

object_name: de Quervain disease


subject: UMLS:C5690426

object_name: Hepatic impairment


subject: GTOPDB:13709

subject_name: olpasiran

object_name: atherosclerosis


subject: DRUGBANK:DB19001

subject_name: Olpasiran


subject: CHEBI:15365

subject_name: Aspirin

object_name: end stage renal failure


subject: CHEBI:15365

object_name: Chronic uremia


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Hodgkin Disease


subject: UNII:7XL5ISS668

object_name: Adult Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:15713

subject_name: UTP

object_name: lung cancer


subject: CHEBI:15713

object_name: lung neoplasm


subject: CHEBI:15713

object_name: lung carcinoma


subject: CHEBI:46398


subject: CHEBI:46398


subject: CHEBI:46398


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Klatskin Tumor


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: liver carcinoma


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: HMDB:HMDB0014370

subject_name: Gadodiamide

object_name: kidney failure


subject: HMDB:HMDB0014370

object_name: chronic kidney disease


subject: HMDB:HMDB0014370

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0722252

subject_name: Omniscan


subject: UMLS:C0722252


subject: UMLS:C0722252


subject: CHEBI:37333


subject: CHEBI:37333


subject: CHEBI:37333


subject: UNII:OWK8BG0FO6

object_name: biliary tract cancer


subject: UNII:OWK8BG0FO6

object_name: bile duct carcinoma


subject: UNII:OWK8BG0FO6

object_name: bile duct cancer


subject: UNII:OWK8BG0FO6

object_name: cholangiocarcinoma


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140


subject: UMLS:C4725831


subject: UMLS:C4725831


subject: UMLS:C4725831


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C5417894

subject_name: Anti-TIM3 Monoclonal Antibody SHR-1702


subject: CHEBI:84500

subject_name: varenicline

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Maternity blues


subject: CHEBI:174615

object_name: leukemia


subject: CHEBI:174615

object_name: childhood leukemia


subject: CHEBI:174615

object_name: adult lymphoma


subject: CHEBI:174615

object_name: lymphoma


subject: CHEBI:174615

object_name: pediatric lymphoma


subject: CHEBI:174615

object_name: acute lymphoblastic leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: acquired polycythemia vera


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: bladder tumor


subject: UNII:28X28X9OKV

object_name: urinary bladder carcinoma


subject: UNII:28X28X9OKV

object_name: urinary bladder cancer


subject: UNII:28X28X9OKV

object_name: childhood bladder carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Metastatic Renal Cell Cancer


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UNII:NS3988A2TC

subject_name: Selonsertib

object_name: alcoholic hepatitis


subject: UMLS:C4726586

subject_name: ADC DS-1062a

object_name: non-small cell lung carcinoma


subject: CHEBI:84040

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:84040

object_name: metabolic syndrome X


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:8871

subject_name: Risperidone

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:44195571

object_name: cancer


subject: PUBCHEM.COMPOUND:44195571

object_name: neoplasm


subject: UNII:BF52J69Q8T


subject: UNII:BF52J69Q8T


subject: UMLS:C4550039

object_name: multiple sclerosis


subject: GTOPDB:8923

subject_name: opicinumab


subject: UNII:WX1WTN0Y15


subject: UMLS:C4550038


subject: CHEBI:18145

subject_name: Vitamin E

object_name: migraine


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C0377786

subject_name: Visipaque

object_name: chronic kidney disease


subject: CHEBI:31705

subject_name: Iodixanol


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: actinic keratosis


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:36704

subject_name: Imiquimod


subject: CHEBI:201443


subject: UNII:7686S50JAH

subject_name: ingenol mebutate


subject: CHEBI:60799

subject_name: Esketamine

object_name: major depressive disorder


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: HIV infection


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: 3MC syndrome 2


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:5300

subject_name: STREPTOZOTOCIN


subject: CHEBI:9288

subject_name: Streptozocin


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C4733069

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:7465

subject_name: Naltrexone

object_name: central sleep apnea syndrome


subject: UMLS:C2605974

subject_name: wenxin keli

object_name: angina unstable


subject: UMLS:C2605974

object_name: coronary artery disorder


subject: CHEBI:6427

subject_name: Leuprolide

object_name: prostate carcinoma


subject: CHEBI:6427

object_name: prostate cancer


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: neuropathy


subject: CHEBI:17858

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:17858

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:17858

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:17858

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:17858

object_name: Ovarian cancer stage IV


subject: CHEBI:17858

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:17858

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:17858

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:17858

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:17858

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:17858

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:17858

object_name: neurotoxicity


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)

object_name: neuropathy


subject: CHEBI:177535

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:177535

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:177535

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177535

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:177535

object_name: Ovarian cancer stage IV


subject: CHEBI:177535

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:177535

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177535

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:177535

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177535

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:177535

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:177535

object_name: neurotoxicity


subject: CHEBI:57925

object_name: neuropathy


subject: CHEBI:57925

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:57925

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:57925

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:57925

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:57925

object_name: Ovarian cancer stage IV


subject: CHEBI:57925

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:57925

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:57925

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:57925

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:57925

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:57925

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:57925

object_name: neurotoxicity


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate

object_name: neuropathy


subject: CHEBI:177258

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:177258

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:177258

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177258

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:177258

object_name: Ovarian cancer stage IV


subject: CHEBI:177258

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:177258

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177258

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:177258

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:177258

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:177258

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:177258

object_name: neurotoxicity


subject: CHEBI:16856

subject_name: Glutathione

object_name: neuropathy


subject: CHEBI:16856

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:16856

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:16856

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:16856

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:16856

object_name: Ovarian cancer stage IV


subject: CHEBI:16856

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:16856

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:16856

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:16856

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:16856

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:16856

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:16856

object_name: neurotoxicity


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube transitional cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: primary peritoneal serous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: peritoneal serous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube mucinous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian transitional cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube endometrioid adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian Brenner tumor


subject: UNII:2S9ZZM9Q9V

object_name: undifferentiated ovarian carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian clear cell malignant adenofibroma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian seromucinous carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian serous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Primary mucinous adenocarcinoma of ovary


subject: UNII:2S9ZZM9Q9V

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:31355

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:31355

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:31355

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:31355

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:31355

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:31355

object_name: ovarian transitional cell carcinoma


subject: CHEBI:31355

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:31355

object_name: ovarian Brenner tumor


subject: CHEBI:31355

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:31355

object_name: ovarian clear cell malignant adenofibroma


subject: CHEBI:31355

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:31355

object_name: ovarian seromucinous carcinoma


subject: CHEBI:31355

object_name: ovarian serous adenocarcinoma


subject: CHEBI:31355

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:31355

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:45863

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:45863

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:45863

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:45863

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:45863

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:45863

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:45863

object_name: ovarian transitional cell carcinoma


subject: CHEBI:45863

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:45863

object_name: ovarian Brenner tumor


subject: CHEBI:45863

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:45863

object_name: ovarian clear cell malignant adenofibroma


subject: CHEBI:45863

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:45863

object_name: ovarian seromucinous carcinoma


subject: CHEBI:45863

object_name: ovarian serous adenocarcinoma


subject: CHEBI:45863

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:45863

object_name: ovarian mucinous adenocarcinoma


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: Cirrhosis


subject: UMLS:C0002521

object_name: liver cirrhosis


subject: UMLS:C0002521

object_name: liver carcinoma


subject: UMLS:C0002521

object_name: liver failure


subject: CHEBI:94782

subject_name: Cediranib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:94782

object_name: metastatic prostate carcinoma


subject: CHEBI:94782

object_name: Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation


subject: CHEBI:94782

object_name: Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation


subject: CHEBI:94782

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:94782

object_name: Prostate Adenocarcinoma with Neuroendocrine Differentiation


subject: CHEBI:5931

subject_name: insulin human

object_name: diabetes mellitus


subject: UMLS:C0876064

subject_name: Lantus


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: renal carcinoma


subject: GTOPDB:4942

object_name: kidney neoplasm


subject: GTOPDB:4942

object_name: kidney cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: UNII:G8RGG88B68


subject: UNII:G8RGG88B68


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:185135

subject_name: Polyvidone

object_name: Pleural effusion


subject: CHEBI:185135

object_name: Pleural Effusion, CTCAE


subject: CHEBI:185135

object_name: x-ray of chest: pleural effusion


subject: CHEBI:185135

object_name: Malignant pleural effusion


subject: CHEBI:185135

object_name: Pleural effusions, chronic


subject: CHEBI:185135

object_name: Pleural effusion due to congestive heart failure


subject: CHEBI:185135

object_name: Pleural effusion in conditions classified elsewhere


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: CHEBI:8347


subject: CHEBI:8347


subject: CHEBI:8347


subject: CHEBI:8347


subject: CHEBI:8347


subject: MESH:C559986

object_name: Dust mite allergy


subject: UMLS:C1456762

object_name: actinic keratosis


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: non-small cell lung carcinoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:167574

subject_name: Semaglutide

object_name: endogenous depression


subject: CHEBI:167574

object_name: major depressive disorder


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: acute bronchiolitis


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Critical Illness


subject: CHEBI:28939

object_name: contrast-induced nephropathy


subject: CHEBI:119915

subject_name: Fentanyl

object_name: sickle cell disease


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: rheumatoid arthritis


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: cutis laxa


subject: PR:000004521

subject_name: advillin


subject: CHEBI:5779

subject_name: Hydrocodone


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:31781

subject_name: Lopinavir

object_name: HIV infection


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: neurodermatitis


subject: UNII:420K487FSG

object_name: Lichen Simplex Chronicus


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:49603

subject_name: Lapatinib

object_name: ductal breast carcinoma in situ


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: wet macular degeneration


subject: CHEBI:231614

subject_name: Nivolumab

object_name: skin squamous cell carcinoma


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: CHEBI:134991

subject_name: Frovatriptan

object_name: Metrorrhagia


subject: CHEBI:134991

object_name: Menstrual spotting


subject: CHEBI:134991

object_name: migraine


subject: CHEBI:134991

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:71587917

object_name: hepatitis C


subject: UMLS:C3852614


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:9123

subject_name: Sertraline


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: CHEBI:63631

subject_name: Topiramate

object_name: Compulsion


subject: CHEBI:75323

subject_name: Lactitol

object_name: Fecal Impaction


subject: CHEBI:75323

object_name: Dysfunction of urinary bladder


subject: CHEBI:75323

object_name: bowel dysfunction


subject: CHEBI:75323

object_name: intestinal disorder


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518

object_name: abortion


subject: CHEBI:94518

object_name: Blood Loss


subject: CHEBI:49005

subject_name: Deferasirox


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: vulva cancer


subject: PUBCHEM.COMPOUND:2767

object_name: vulva carcinoma


subject: CHEBI:91518

subject_name: Etilefrine

object_name: Hepatic ascites


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: endogenous depression


subject: CHEBI:25681

object_name: major depressive disorder


subject: CHEBI:25681

object_name: cardiovascular disorder


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Childhood Solid Neoplasm


subject: UNII:KXG2PJ551I

object_name: Adult Solid Neoplasm


subject: UNII:KXG2PJ551I

object_name: Solid Neoplasm


subject: UNII:KXG2PJ551I

object_name: non-small cell lung carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001


subject: CHEBI:3223

subject_name: Buspirone

object_name: Esophageal Dysphagia


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated

object_name: poliomyelitis


subject: UMLS:C1121680

subject_name: TMC 125

object_name: HIV infection


subject: CHEBI:49166

subject_name: fluorodopa F 18

object_name: insulinoma


subject: CHEBI:49166

object_name: Perlman syndrome


subject: CHEBI:49166

object_name: Beckwith-Wiedemann syndrome


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: congenital alveolar dysplasia


subject: PUBCHEM.COMPOUND:6435378

object_name: respiratory distress syndrome in premature infants


subject: PUBCHEM.COMPOUND:6435378

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:6435378

object_name: newborn respiratory distress syndrome


subject: PUBCHEM.COMPOUND:6435378

object_name: Persistent pulmonary hypertension


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: gastric cancer


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: breast neoplasm


subject: UNII:4W3KFI3TN3

subject_name: Talquetamab

object_name: plasma cell myeloma


subject: UMLS:C4687984

subject_name: talquetamab


subject: UNII:54534MX6Z9

subject_name: Teclistamab


subject: UMLS:C4527013


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Small cell lung cancer extensive stage


subject: UNII:1CIV2UMO40

subject_name: Minnelide

object_name: acute myeloid leukemia by FAB classification


subject: UNII:1CIV2UMO40

object_name: acute myeloid leukemia


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: cannabis abuse


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: MESH:D010919

subject_name: Placebos


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: Primary human immunodeficiency virus infection


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: diabetic polyneuropathy


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:16494

subject_name: thioctic acid


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:31781

subject_name: Lopinavir

object_name: tuberculosis


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409

object_name: HIV infection


subject: CHEBI:63613

subject_name: Nevirapine


subject: CHEBI:63613


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Follicular lymphoma refractory


subject: CHEBI:231598

object_name: Follicular lymphoma recurrent


subject: UNII:U59UGK3IPC

subject_name: Ublituximab


subject: UNII:U59UGK3IPC


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib


subject: UNII:38073MQB2A


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Azathioprine adverse reaction


subject: CHEBI:2948

object_name: neuromyelitis optica


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: IgA Nephropathy


subject: UNII:C3VX249T6L

object_name: IgA nephropathy, susceptibility to, 1


subject: UNII:C3VX249T6L

object_name: Henoch-Schonlein purpura nephritis


subject: UNII:C3VX249T6L

object_name: IgA vasculitis


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: tracheobronchitis


subject: PUBCHEM.COMPOUND:76322320

object_name: pneumonia


subject: PUBCHEM.COMPOUND:76322320

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:37943


subject: UMLS:C3640806

object_name: Solid Neoplasm


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: alcoholic hepatitis


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:8378

subject_name: Prednisolone


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: PR:000001379


subject: CHEBI:149504

object_name: hypertension


subject: CHEBI:149504

object_name: Hypertension, CTCAE


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:7476

subject_name: Naproxen

object_name: gout


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:54675783

object_name: major depressive disorder


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: beta thalassemia


subject: UNII:AQK7UBA1LS

object_name: beta-thalassemia HBB/LCRB


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355

object_name: bladder tumor


subject: CHEBI:31355

object_name: urinary bladder carcinoma


subject: CHEBI:31355

object_name: urinary bladder cancer


subject: CHEBI:31355

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE


subject: CHEBI:7459

subject_name: Naloxone


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Postoperative retention of urine


subject: CHEBI:3215

object_name: Postoperative Complications


subject: CHEBI:9241

subject_name: Spironolactone

object_name: end stage renal failure


subject: CHEBI:9241

object_name: Chronic uremia


subject: CHEBI:9241

object_name: heart failure


subject: CHEBI:9241

object_name: congestive heart failure


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Cannabis use


subject: CHEBI:22586

subject_name: antioxidant

object_name: Smith-Lemli-Opitz syndrome


subject: CHEBI:22586

object_name: Leber congenital amaurosis 4


subject: CHEBI:22586

object_name: AIPL1-related retinopathy


subject: CHEBI:22586

object_name: cone-rod dystrophy 2


subject: CHEBI:22586

object_name: cone-rod dystrophy


subject: CHEBI:22586

object_name: deafness


subject: CHEBI:22586

object_name: hearing loss by exam


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: CHEBI:16113

subject_name: Cholesterol


subject: CHEBI:16113


subject: CHEBI:16113


subject: CHEBI:16113


subject: CHEBI:16113


subject: CHEBI:16113


subject: CHEBI:16113


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:233362

object_name: Metastatic Breast Carcinoma


subject: CHEBI:233362

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: HMDB:HMDB0033240

subject_name: Grevilline B

object_name: urothelial carcinoma


subject: HMDB:HMDB0033240

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:41744

subject_name: Valrubicin


subject: PUBCHEM.COMPOUND:41744


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Neck Carcinoma


subject: GTOPDB:12989

object_name: head and neck neoplasm


subject: GTOPDB:12989

object_name: head and neck cancer


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEMBL.COMPOUND:CHEMBL2109482

object_name: plasma cell myeloma


subject: UMLS:C2981844

subject_name: Bersanlimab


subject: UMLS:C5815513

subject_name: Japanese Encephalitis Vaccine, Inactivated, Adsorbed

object_name: Zika fever


subject: UMLS:C2682870

subject_name: Ixiaro


subject: CHEBI:231679

subject_name: ipilimumab

object_name: endometrial transitional cell carcinoma


subject: CHEBI:231679

object_name: transitional cell carcinoma of the corpus uteri


subject: CHEBI:231679

object_name: ureter adenocarcinoma


subject: CHEBI:231679

object_name: gestational trophoblastic neoplasm


subject: CHEBI:231679

object_name: mucinous adenocarcinoma


subject: CHEBI:231679

object_name: nasopharyngeal carcinoma


subject: CHEBI:231679

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:231679

object_name: undifferentiated carcinoma of nasopharynx


subject: CHEBI:231679

object_name: cholangiocarcinoma


subject: CHEBI:231679

object_name: bladder adenocarcinoma


subject: CHEBI:231679

object_name: pancreatic endocrine carcinoma


subject: CHEBI:231679

object_name: Neuroendocrine carcinoma of pancreas


subject: CHEBI:231679

object_name: Plexosarcoma


subject: CHEBI:231679

object_name: paraganglioma


subject: CHEBI:231679

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:231679

object_name: adrenal cortex carcinoma


subject: CHEBI:231679

object_name: adenoid cystic carcinoma


subject: CHEBI:231679

object_name: Intestinal Neuroendocrine Carcinoma


subject: CHEBI:231679

object_name: chordoma


subject: CHEBI:231679

object_name: PEComa


subject: CHEBI:231679

object_name: vulva carcinoma


subject: CHEBI:231679

object_name: serous adenocarcinoma


subject: CHEBI:231679

object_name: serous cystadenocarcinoma


subject: CHEBI:231679

object_name: transitional cell carcinoma


subject: CHEBI:231679

object_name: seminoma


subject: CHEBI:231679

object_name: testicular germ cell tumor


subject: CHEBI:231679

object_name: testis seminoma


subject: CHEBI:231679

object_name: lung giant cell carcinoma


subject: CHEBI:231679

object_name: gallbladder carcinoma


subject: CHEBI:231679

object_name: acinar cell carcinoma


subject: CHEBI:231679

object_name: pediatric angiosarcoma


subject: CHEBI:231679

object_name: angiosarcoma


subject: CHEBI:231679

object_name: Adult Angiosarcoma


subject: CHEBI:231679

object_name: basal cell carcinoma


subject: CHEBI:231679

object_name: skin basal cell carcinoma


subject: CHEBI:231679

object_name: squamous cell carcinoma of the small intestine


subject: CHEBI:231679

object_name: ovarian transitional cell carcinoma


subject: CHEBI:231679

object_name: mucinous cystadenocarcinoma


subject: CHEBI:231679

object_name: Oropharyngeal lymphoepithelioma


subject: CHEBI:231679

object_name: major salivary gland carcinoma


subject: CHEBI:231679

object_name: small intestine adenocarcinoma


subject: CHEBI:231679

object_name: parathyroid gland carcinoma


subject: CHEBI:231679

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:231679

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:231679

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:231679

object_name: ureter squamous cell carcinoma


subject: CHEBI:231679

object_name: thyroid gland carcinoma


subject: CHEBI:231679

object_name: nasal cavity carcinoma


subject: CHEBI:231679

object_name: cervical adenocarcinoma


subject: CHEBI:231679

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:231679

object_name: malignant peripheral nerve sheath tumor


subject: CHEBI:231679

object_name: adult malignant schwannoma


subject: CHEBI:231679

object_name: childhood malignant schwannoma


subject: CHEBI:231679

object_name: undifferentiated carcinoma of esophagus


subject: CHEBI:231679

object_name: trachea carcinoma


subject: CHEBI:231679

object_name: Esophageal Neuroendocrine Carcinoma


subject: CHEBI:231679

object_name: mucinous adenocarcinoma of the appendix


subject: CHEBI:231679

object_name: adrenal gland pheochromocytoma


subject: CHEBI:231679

object_name: nasal cavity adenocarcinoma


subject: CHEBI:231679

object_name: ovarian squamous cell carcinoma


subject: CHEBI:231679

object_name: undifferentiated carcinoma of anal canal


subject: CHEBI:231679

object_name: oral cavity carcinoma


subject: CHEBI:231679

object_name: sex cord-stromal tumor


subject: CHEBI:231679

object_name: testicular sex cord-stromal neoplasm


subject: CHEBI:231679

object_name: metaplastic breast carcinoma


subject: CHEBI:231679

object_name: neuroendocrine carcinoma of anal canal


subject: CHEBI:231679

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:231679

object_name: extramammary Paget disease


subject: CHEBI:231679

object_name: lung sarcomatoid carcinoma


subject: CHEBI:231679

object_name: Gastric neuroendocrine carcinoma


subject: CHEBI:231679

object_name: urethra squamous cell carcinoma


subject: CHEBI:231679

object_name: ovarian germ cell tumor


subject: CHEBI:231679

object_name: pediatric ovarian germ cell tumor


subject: CHEBI:231679

object_name: lung neuroendocrine neoplasm


subject: CHEBI:231679

object_name: lung carcinoid tumor


subject: CHEBI:231679

object_name: ovarian adenocarcinoma


subject: CHEBI:231679

object_name: scrotum squamous cell carcinoma


subject: CHEBI:231679

object_name: peritoneal mesothelioma


subject: CHEBI:231679

object_name: vaginal squamous cell carcinoma


subject: CHEBI:231679

object_name: endometrioid adenocarcinoma


subject: CHEBI:231679

object_name: squamous cell carcinoma of penis


subject: CHEBI:231679

object_name: undifferentiated carcinoma of stomach


subject: CHEBI:231679

object_name: Bartholin gland transitional cell carcinoma


subject: CHEBI:231679

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:231679

object_name: pituitary adenocarcinoma


subject: CHEBI:231679

object_name: gastric squamous cell carcinoma


subject: CHEBI:231679

object_name: colorectal squamous cell carcinoma


subject: CHEBI:231679

object_name: vaginal adenocarcinoma


subject: CHEBI:231679

object_name: paranasal sinus carcinoma


subject: CHEBI:231679

object_name: testicular non-seminomatous germ cell tumor


subject: CHEBI:231679

object_name: spindle cell neoplasm


subject: CHEBI:231679

object_name: Malignant odontogenic tumor


subject: CHEBI:231679

object_name: Nasopharyngeal Low Grade Papillary Adenocarcinoma


subject: CHEBI:231679

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:231679

object_name: urethra adenocarcinoma


subject: CHEBI:231679

object_name: fibromatosis


subject: CHEBI:231679

object_name: desmoid tumor


subject: CHEBI:231679

object_name: pseudomyxoma peritonei


subject: CHEBI:231679

object_name: teratoma with malignant transformation


subject: CHEBI:231679

object_name: placental choriocarcinoma


subject: CHEBI:231679

object_name: carcinosarcoma


subject: CHEBI:231679

object_name: seminal vesicle adenocarcinoma


subject: CHEBI:231679

object_name: cervical clear cell adenocarcinoma


subject: CHEBI:231679

object_name: fallopian tube adenocarcinoma


subject: CHEBI:231679

object_name: apocrine sweat gland neoplasm


subject: CHEBI:231679

object_name: Myxofibroma


subject: CHEBI:231679

object_name: Malignant Solid Neoplasm


subject: CHEBI:231679

object_name: Rare Diseases


subject: CHEBI:231614

subject_name: Nivolumab

object_name: endometrial transitional cell carcinoma


subject: CHEBI:231614

object_name: transitional cell carcinoma of the corpus uteri


subject: CHEBI:231614

object_name: ureter adenocarcinoma


subject: CHEBI:231614

object_name: gestational trophoblastic neoplasm


subject: CHEBI:231614

object_name: mucinous adenocarcinoma


subject: CHEBI:231614

object_name: nasopharyngeal carcinoma


subject: CHEBI:231614

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:231614

object_name: undifferentiated carcinoma of nasopharynx


subject: CHEBI:231614

object_name: cholangiocarcinoma


subject: CHEBI:231614

object_name: bladder adenocarcinoma


subject: CHEBI:231614

object_name: pancreatic endocrine carcinoma


subject: CHEBI:231614

object_name: Neuroendocrine carcinoma of pancreas


subject: CHEBI:231614

object_name: Plexosarcoma


subject: CHEBI:231614

object_name: paraganglioma


subject: CHEBI:231614

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:231614

object_name: adrenal cortex carcinoma


subject: CHEBI:231614

object_name: adenoid cystic carcinoma


subject: CHEBI:231614

object_name: Intestinal Neuroendocrine Carcinoma


subject: CHEBI:231614

object_name: chordoma